Application of a novel phenylpiperazine formation reaction to the radiosynthesis of a model fluorine-18-labeled radiopharmaceutical (18FTFMPP)

Nuclear Medicine and Biology

Volumn 24, Issue 3, 1997, Pages 269-273

  Mishani, Eyal ^a   Cristel, Michael E ^a   Dence, Carmen S ^a   McCarthy, Timothy J ^a   Welch, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

18F Fluoride; Phenylpiperazine; Serotonin; TFMPP

Indexed keywords

3 FLUORO N (1,1,1 TRIFLUORO 3 TOLYL)PIPERAZINE F 18; PIPERAZINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; DRUG BINDING; DRUG DISTRIBUTION; DRUG PURIFICATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; DRUG UPTAKE; ISOTOPE LABELING; MEMBRANE BIOLOGY; NONHUMAN; RECEPTOR AFFINITY; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; FLUORINE RADIOISOTOPES; ISOTOPE LABELING; LIGANDS; MEMBRANES; PIPERAZINES; RADIOPHARMACEUTICALS; RATS; RECEPTORS, SEROTONIN; SEROTONIN AGENTS; TISSUE DISTRIBUTION;

EID: 0030738287     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00063-2     Document Type: Article

References (23)

1. Abdul M., Anezinis P. E., Logothetis C. J. and Hoosein N. M. (1994) Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonist. Anticancer Res. 14, 1215-1220.
2. Abrahamsson P. A., Wadstrom L. B., Alumets J., Falkmer S. and Grimelius L. (1986) Peptide-hormone and serotonin immunoreactive cells in normal and hyperplastic prostate glands. Pathol. Res. Pract. 181, 675-681
3. 18F]fluoro-m-tolyl)piperazine: A potent serotonin agonist. J. Label. Compd. Radiopharm. 28, 1441-1448.
4. 1B heterogeneity. Life Sci. 36, 1265-1273.
5. Boyfield I., Coldwell M. C., Hadley M. S., Healy M. A. M., Johns A., Nash D. J., Riley G. J., Scott E. E., Smith S. A., Stemp G. and Wilson K. (1996) N-(substituted-phenyl)piperazine: Antagonists with high binding and functional selectivity for dopamine D4 receptors. Bioorg. Med. Chem. Lett. 6, 1227-1232.
6. 2 antagonist). J. Chem. Soc., Perkin Trans. 1, 3185-3188.
7. Fuller R. W., Mason N. R. and Molloy B. B. (1980) Structural relationships in the inhibition of [3H]serotonin binding to rat brain membranes in vitro by 1-phenyl-piperazines. Biochem. Pharmacol. 29, 833-855.
8. S. Glennon R. A. (1987) Central serotonin receptors as target for drug research. J. Med. Chem. 30, 1-12.
9. Glennon R. A. (1990) Serotonin receptors: Clinical implications. Neurosci. Biobehav. Rev. 14, 35-47.
10. Glennon R. A. (1990) Functional/clinical significance of 5-hydroxytryptamine binding sites. In: Serotonin: From Cell Biology to Pharmacology and Therapeutics (Edited by Paoletti R), p. 259. Kluwer Academic Publishers, New York.
11. Hennig I. M., Laissue J. A., Horisberger U. and Reubi J. C. (1995) Substance P receptors in human primary neoplasms: Tumoural and vascular localisation. Int. J. Cancer 61, 786-792.
12. Hoosein N. M., Logothetis C. J. and Chung L. W. (1993) Differential effects of peptide hormones bombesin, vascoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J. Urol. 149, 1209-1213.
13. 2A receptors. J. Label. Compd. Radiopharm. 37, 299-301.
14. Kulagowski J. J., Broughton H. B., Curtis N. R., Mawer I. M., Ridgill M. P., Baker R. and Emms F. (1996) 3-((4-C4-chlorophenylpiperazine-1-yl)-methyl)-1H-pyrolo-2,3β-pyridine: An antagonist with high affinity and selectivity for human dopamine D4 receptor. J. Med. Chem. 39, 1941-1942.
15. 1B binding sites. Soc. Neurosci. Abstr. 14, 555.
16. 1A receptors. J. Label. Compd. Radiopharm. 37, 289-291.
17. 18F]fluoro-for-nitro exchange: A useful intermediate in the synthesis of highly fluorinated radiopharmaceuticals. J. Label. Compd. Radiopharm. 37, 575-578.
18. Mishani E., Dence C. S., McCarthy T. J. and Welch M. J. (1996) Formation of phenylpiperazine by a novel alumina supported bisalkylation. Tetrahedron Lett 37, 319-322.
19. Mueller E. A., Murphy D. L, and Sunderland T. (1986) Further studies of the putative serotonin agonist m-chlorophenylpiperazine: Evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology 89, 388-391.
20. Posner G. H. (1978) New synthetic methods: 24. Organic reactions on aluminum oxide surfaces. Angew. Chem. 90, 527-536.
21. Reubi J. C. (1995) Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging. J. Nucl. Med. 36, 1825-1835.
22. 18O]water using anion exchange resin. Appl. Radiat. Isot. 41, 531-533.
23. 1A ligand. J. Med. Chem. 37, 1406-1407.